logo
Select company
Select metric
$ 2.83MTotal Debt
VS
Market
81
Sector
69
Industry
60
History
14
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information

Ticker

BBOT

Company Name

BRIDGEBIO ONCOLOGY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIDGEBIO ONCOLOGY THERAPEUTICS INC - Total Debt Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBOT - Debt Historical data
DateTotal Debt
6/30/2025$ 2.83M
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 70.09K
9/30/2023$ 43.4M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) Debt stands at $ 43.4M.
  • Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average Debt has been $ 5.79M.
  • The median Debt for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was $ 0
  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest Debt over the past 5 years at $ 43.4M.
  • The lowest Debt recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe $ 0

Definition of Total Debt

[Balance Sheet] The total debt is a component of [Liabilities] that represents principle balances held in exchange for interest paid (also know as loans). Includes secured and unsecured bonds issued, commercial paper, notes payable credit facilities, lines of credit, capital lease obligations, operating lease obligations, and convertible notes.

BBOT - Total Debt, Last 5 years

$ 0

Minimum

Mar 31, 2024

$ 43.4M

Maximum

Sep 30, 2023

$ 5.79M

Average

$ 0

Median

Debt Benchmark Analysis

The chart above depicts the distribution of Debt for companies in the Total Stock Market. The average Debt of the companies is $ 182.37M with a standard deviation of $ 275.77M.
The following table provides additional summary stats:
Debt in the Market:
filtered constituents3.18K
min$ 0
max$ 1.14B
average$ 182.37M
median$ 37.73M
std$ 275.77M